Sigma Planning Corp’s Corbus Pharmaceuticals CRBP Stock Holding History

Sigma Planning Corp’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,067	Closed	-$3.54K	–	1306
2022 Q4	$3.54K	Hold	1,067	–	–	﹤0.01%	1253
2022 Q3	$5K	Hold	1,067	–	–	﹤0.01%	1254
2022 Q2	$8K	Hold	1,067	–	–	﹤0.01%	1282
2022 Q1	$17K	Hold	1,067	–	–	﹤0.01%	1355
2021 Q4	$20K	Hold	1,067	–	–	﹤0.01%	1374
2021 Q3	$33K	Hold	1,067	–	–	﹤0.01%	1358
2021 Q2	$59K	Hold	1,067	–	–	﹤0.01%	1391
2021 Q1	$63K	Hold	1,067	–	–	﹤0.01%	1303
2020 Q4	$40K	Hold	1,067	–	–	﹤0.01%	1178
2020 Q3	$58K	Buy	+1,067	New	+$193K	﹤0.01%	1034

Other funds holding CRBP

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Sigma Planning Corp's CRBP Position: Q1 2023 in Review

Sigma Planning Corp sold out of Corbus Pharmaceuticals (CRBP) in Q1 2023, closing a stake of 1,067 shares — an estimated $3.54K sold.

Sigma Planning Corp first reported a position in CRBP in Q3 2020 and held it in 10 quarters. The position peaked at $63K in Q1 2021. 30 funds tracked by Wall St. Rank hold CRBP as of Q1 2023.

Sigma Planning Corp reported no remaining Corbus Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Sigma Planning Corp sold 1,067 Corbus Pharmaceuticals shares in Q1 2023, an estimated $3.54K.
Sigma Planning Corp first reported a position in Corbus Pharmaceuticals in Q3 2020 and held it in 10 quarters.
Sigma Planning Corp's Corbus Pharmaceuticals position peaked at $63K in Q1 2021.
30 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2023.

Based on Sigma Planning Corp's 13F filing for Q1 2023, filed 8 May 2023.